Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L42 pseudogene 4 (MRPL42P4) is a noncoding pseudogene in humans, structurally related to the gene encoding mitochondrial ribosomal protein L42. The functional MRPL42 is a component of the mitochondrial ribosome and contributes to mitochondrial protein synthesis. Pseudogenes such as MRPL42P4 result from duplication or retrotransposition events and lack protein-coding capacity. MRPL42P4 is one of several pseudogenes annotated for the MRPL42 locus in the human genome; pseudogenes from ribosomal protein families are common and may sometimes influence gene regulation, but there is no evidence of specific biological or therapeutic functions for MRPL42P4. The MRPL42 gene (not the pseudogene) encodes a protein involved in mitochondrial translation and is associated with structural roles in the mitochondrial ribosome. MRPL42 has established protein-coding, disease associations, and molecular functions, but these do not extend to MRPL42P4. For other ribosomal protein pseudogenes, there is emerging evidence that they may act as regulatory elements or have roles in cancer progression or immune modulation, but MRPL42P4 is not currently implicated or demonstrated in any such context. In summary, MRPL42P4 is best classified as a ribosomal protein pseudogene, not a canonical drug target; it does not encode a protein and has no documented disease, drug, or biomarker associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L42 pseudogene 4 (MRPL42P4).